HLA association with the susceptibility to anti-synthetase syndrome.

[1]  M. González-Gay,et al.  Influence of MUC5B gene on antisynthetase syndrome , 2020, Scientific Reports.

[2]  Annette Lee,et al.  Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups , 2019, Annals of the rheumatic diseases.

[3]  M. Guiguet,et al.  Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies , 2018, JAMA neurology.

[4]  M. González-Gay,et al.  Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study , 2018, The Journal of Rheumatology.

[5]  P. Szodoray,et al.  Effect of Genetic and Laboratory Findings on Clinical Course of Antisynthetase Syndrome in a Hungarian Cohort , 2018, BioMed research international.

[6]  M. Nalls,et al.  MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease , 2018, The New England journal of medicine.

[7]  P. Froguel,et al.  Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis , 2017, European Respiratory Journal.

[8]  M. González-Gay,et al.  Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study. , 2017, Autoimmunity reviews.

[9]  F. Salaffi,et al.  Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group , 2017, Clinical Reviews in Allergy & Immunology.

[10]  E. Unanue,et al.  Variations in MHC Class II Antigen Processing and Presentation in Health and Disease. , 2016, Annual review of immunology.

[11]  P. Gregersen,et al.  Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes , 2015, Genes and Immunity.

[12]  M. González-Gay,et al.  Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome , 2015, Medicine.

[13]  A. Mirrakhimov.  Antisynthetase syndrome: a review of etiopathogenesis, diagnosis and management. , 2015, Current medicinal chemistry.

[14]  R. Prayson,et al.  Antisynthetase syndrome: Not just an inflammatory myopathy , 2013, Cleveland Clinic Journal of Medicine.

[15]  F. Meloni,et al.  Cyclosporine in Anti-Jo1-positive Patients with Corticosteroid-refractory Interstitial Lung Disease , 2013, The Journal of Rheumatology.

[16]  M. Guiguet,et al.  Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity. , 2012, Autoimmunity reviews.

[17]  L. Alfredsson,et al.  Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study , 2011, Annals of the rheumatic diseases.

[18]  V. Limaye,et al.  Clinical heterogeneity and prognostic features of South Australian patients with anti‐synthetase autoantibodies , 2011, Internal medicine journal.

[19]  J. Reveille,et al.  HLA-D region genes associated with autoantibody responses to histidyl-transfer RNA synthetase (Jo-1) and other translation-related factors in myositis. , 2010, Arthritis and rheumatism.

[20]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[21]  M. Carrington,et al.  Immunogenetic Risk and Protective Factors for the Idiopathic Inflammatory Myopathies: Distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 Allelic Profiles Distinguish European American Patients With Different Myositis Autoantibodies , 2006, Medicine.

[22]  A. Silman,et al.  In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype , 2005, Arthritis research & therapy.

[23]  Annette Lee,et al.  Analysis of Families in the Multiple Autoimmune Disease Genetics Consortium (madgc) Collection: the Ptpn22 620w Allele Associates with Multiple Autoimmune Phenotypes , 2022 .

[24]  J. Dausset,et al.  Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[25]  JL Newton,et al.  A review of the MHC genetics of rheumatoid arthritis , 2004, Genes and Immunity.

[26]  C. Caruso,et al.  Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions. , 2002, Autoimmunity reviews.

[27]  E. Wakeland,et al.  The genetics of complex autoimmune diseases: non-MHC susceptibility genes , 2001, Nature Immunology.

[28]  J. Klein,et al.  The HLA system. Second of two parts. , 2000 .

[29]  F. Christiansen,et al.  The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases , 1999, Immunological reviews.

[30]  F. Arnett,et al.  The genetics of lupus. , 1998, Current opinion in rheumatology.

[31]  J. Reveille,et al.  Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis. , 1996, Arthritis and rheumatism.

[32]  F. Christiansen,et al.  An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes , 1992, Immunogenetics.

[33]  M. Dalakas,et al.  A New Approach to the Classification of Idiopathic Inflammatory Myopathy: Myositis‐Specific Autoantibodies Define Useful Homogeneous Patient Groups , 1991, Medicine.

[34]  F. Christiansen,et al.  Major histocompatibility complex (MHC) complement deficiency, ancestral haplotypes and systemic lupus erythematosus (SLE): C4 deficiency explains some but not all of the influence of the MHC. , 1991, The Journal of rheumatology.

[35]  T. The,et al.  Increased frequency of B8/DR3 in scleroderma and association of the haplotype with impaired cellular immune response. , 1981, Clinical and experimental immunology.

[36]  I. Olivieri,et al.  Timing of onset affects arthritis presentation pattern in antisyntethase syndrome. , 2018, Clinical and experimental rheumatology.

[37]  A. Zhernakova,et al.  Detecting shared pathogenesis from the shared genetics of immune-related diseases , 2009, Nature Reviews Genetics.

[38]  M. Hamidou,et al.  Antisynthetase syndrome. , 2003, Joint, bone, spine : revue du rhumatisme.

[39]  B. Diamond,et al.  Autoimmune diseases , 2000, Bone Marrow Transplantation.

[40]  The Chinese Human Genome Sequencing Consortium,et al.  Complete sequence and gene map of a human major histocompatibility complex , 1999 .